A contaminated heparin lawyer can help Heparin Lawyer

Were you injured from taking the blood thinner heparin? If you are looking for a heparin lawyer due to serious injuries, illness or death of a loved one resulting from the use of contaminated heparin, contact Jim S. Adler & Associates


What is heparin? 

Heparin is an anticoagulant that has been around since the 1930s.  Commonly referred to as a blood thinner, heparin decreases the blood’s clotting ability, and is often administered to patients at risk of developing life-threatening blood clots during surgery or other invasive procedures.  Heparin is also used as a flush product to remove blood clots from IV lines to keep the lines clear.

Heparin is most often given as an injection or through an IV as a bolus dose (a high dose given in a short period of time) during cardiac surgery or kidney dialysis.  Most patients who have experienced problems with heparin received the drug in a bolus dose.  However, a small number of patients experienced problems related to the heparin lock flush solutions. 

Heparin contamination | Heparin FDA recalls

Baxter Heparin

On January 17, 2008, Baxter International, Inc., the manufacturer of multi-dose and single dose vials of heparin sodium injection, initiated a recall of nine lots of its heparin sodium injection.  One month later, Baxter issued an update on its recall referencing patient reactions to lots of heparin sodium injection other than the nine lots recalled.  Although Baxter suspended production of the drug, it continued to distribute its existing product. 

On February 14, 2008, the Wall Street Journal reported that the active ingredient to Baxter’s heparin was supplied by a company called Scientific Protein Laboratories (SPL) with facilities in Wisconsin and China.  The active ingredient was manufactured at both locations. 

On March 5, 2008, the Food & Drug Administration (FDA) reported that it discovered a “heparin-like molecule” in the active ingredient in heparin supplied by SPL, which was supplied to Baxter to make its heparin.  At present, the FDA continues to study Baxter heparin and the contamination with the heparin-like molecule. 

Pre-filled Heparin Syringes

Problems with pre-filled heparin and saline syringes used to flush out long-term IV lines began to surface in October 2007.  Blood infections developed in patients who used these syringes that were manufactured by AM2PAT, Inc. at its North Carolina facility.  AM2PAT focused its attention on a single lot and related infections in Illinois and Texas. Accordingly, AM2PAT began quarantining this lot and withdrawing syringes from the market.  Subsequently, the FDA became involved. It inspected the AM2PAT manufacturing facility and determined the facility failed to have adequate controls to ensure necessary sterility of its pre-filled syringes. 

At present, all pre-filled heparin and saline syringes manufactured by AM2PAT, Inc. have been recalled for potential contamination with serratia marcescens bacteria.  The recall applies to the heparin pre-filled and saline pre-filled syringes distributed under three product labels: Sierra Pre-Filled, AM2PAT, and B. Braun. 

Heparin injuries and side effects

Exposure to contaminated heparin can cause serious injuries and even death.  Hundreds of people have sustained injuries from their use of contaminated heparin. Many have died. Problems that can occur from a reaction to contaminated heparin include organ failure, heart problems, shock, decreased blood pressure, chest pain, abdominal pain, nausea, low energy, fainting, skin redness, increased sweating, throat swelling, shortness of breath, and headaches.  It is essential that anyone experiencing these symptoms contact a medical professional immediately. 

 

If you or a loved one has been harmed due to use of contaminated heparin, contact a heparin attorney with Jim S. Adler & Associates today. The law firm offers a free case review and charges no retainer fees, but only a percent of the recovery should your case prevail.

 

 

HEPARIN ARTICLES...



Pharmaceutical industry geared for profits, not safety

Drug companies know selling worry and doubt makes a profit. Are women benefiting as much as the industry's bottom line?

The fact is that the pharmaceutical industry spent much of its $4.2 billion direct-to-consumer advertising budget in 2005 on ads targeting healthy upper-income, middle-aged people. A common underlying message was this: You appear to be healthy, but a deadly heart attack, hip fracture or other medical catastrophe could occur at any time. Therefore, you should take a prescription drug to prevent such problems.  Was this tactic deliberately geared toward a specific type of person – one who would more than likely feel a “connection” to the advertisements?  Of course.

 


 

Read more...
 

Copyright © 2006-2008 Jim S. Adler & Associates, All Rights Reserved.
The content on JimAdler.com should NOT be taken as a substitute for advice by a competent attorney or medical professional. The site is sponsored by Jim S. Adler & Associates (Principal Office: Houston, Texas Phone: 800-505-1414). Use of this website or submission of an online form does NOT constitute the forming of an attorney-client relationship. Accordingly, no attorney/client relationship is formed until you are contacted by an attorney from Jim S. Adler & Associates and you sign a client agreement. Information contained on JimAdler.com, including, but not limited to written text, images, informational articles, and on or off site links, has not been prepared, endorsed, or reviewed by any form of licensed medical professional, including but not limited to physicians, doctors, and so on. Nothing on this website should be taken as medical advice, but instead should act as a useful resource in providing general information that may be useful to members of the general public. All visitors are encouraged to consult with a physician or other licensed medical professional for any form of medical advice.